A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung Cancer

NCT00437749 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

214

Enrollment

INDUSTRY

Sponsor class

Stopped slow accrual rate; interim accrual objective met

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: CBT-1
OTHER: Placebo

Sponsor

CBA Research